Lipitor (Atorvastatin Calcium)
Brand Names: Lipitor
Methodology & AI Transparency ⓘ
Lipitor (Atorvastatin Calcium) Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Lipitor (Atorvastatin Calcium) represents a prescription brand-name hmg-coa reductase inhibitor entry registered by Viatris Specialty LLC with package codes 58151-157, 58151-155.
- 2 Real-world patient consensus: Branded hmg-coa reductase inhibitor presentation of Atorvastatin Calcium (Viatris Specialty LLC); generic reference: /meds/atorvastatin-calcium.
- 3 Typical cash cost range: Public pharmacy ledger: $5.25 low cash benchmark vs. $34.50 chain retail average ($19.0681/unit CMS NADAC).
- 4 Top reported side effects / signs: Primary clinical safety signals tracked in FAERS for Lipitor (Atorvastatin Calcium) include diarrhea (10%), arthralgia (5.3%), nasopharyngitis (5.8%).
Ask our AI Specialists anything about Lipitor (Atorvastatin Calcium)
Lipitor (Atorvastatin Calcium) Mechanism, CYP450 Pathways & DailyMed Monograph
Lipitor (Atorvastatin Calcium) represents a prescription brand-name hmg-coa reductase inhibitor entry registered by Viatris Specialty LLC with package codes 58151-157, 58151-155. Reviewed against 2026-05-06 FDA SPL standards (40 mg/1 Tablet, Film Coated; 10 mg/1 Tablet, Film Coated), clinical deployment addresses Atorvastatin calcium tablets is indicated: To reduce the risk of: Myocardial infarction (MI), stroke, revascularization.
Lipitor achieves therapeutic action via Atorvastatin Calcium, engaging hmg-coa reductase inhibitor physiological pathways with class-characteristic hepatorenal disposition. Manufactured in 40 mg/1 Tablet, Film Coated; 10 mg/1 Tablet, Film Coated (registered by Viatris Specialty LLC, NDC 58151-157, 58151-155), pharmacists evaluate FDA Orange Book therapeutic equivalence when comparing branded Lipitor ($34.50 retail) with generic Atorvastatin Calcium ($5.25 low cash).
With Mean elimination half-life of 4 to 10 hours across adult Lipitor (Atorvastatin Calcium) dosing residence kinetics and Oral fraction absorbed ranges from 60% to 72% (Lipitor (Atorvastatin Calcium) 40) bioavailability, Lipitor (Atorvastatin Calcium) undergoes dual hepatorenal clearance pathway combining glucuronidation and urinary filtration of lipitor (atorvastatin calcium) and establishes therapeutic activity over oral tmax achieved within 2 to 3 hours following lipitor (atorvastatin calcium) ingestion.
Standard adult regimens span 40 mg/1 Tablet, Film Coated, 10 mg/1 Tablet, Film Coated, 20 mg/1 Tablet, Film Coated, 80 mg/1 Tablet, Film Coated, 10mg Tablet. Prescribers screen specifically against contraindicated in patients with prior serious allergic response to lipitor (atorvastatin calcium) (ndc 58151-157); severe baseline organ impairment where atorvastatin calcium accumulation exceeds safe therapeutic margins, while community micro-logs most frequently note diarrhea (10% of reports), nausea (9.3% of reports), headache (8.6% of reports).
Rifampin or anticonvulsant inducers can diminish Lipitor (Atorvastatin Calcium) systemic exposure and clinical response.
Separate Lipitor (Atorvastatin Calcium) ingestion from mineral supplements or antacids to preserve gastrointestinal bioavailability.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- Contraindicated in patients with prior serious allergic response to Lipitor (Atorvastatin Calcium) (NDC 58151-157)
- Severe baseline organ impairment where Atorvastatin Calcium accumulation exceeds safe therapeutic margins
Logged Side-Effect Incidence (22 Reports)
Lipitor (Atorvastatin Calcium) Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Lipitor (Atorvastatin Calcium))
Human clinical trial evidence for Lipitor (Atorvastatin Calcium) is indexed directly from the U.S. National Library of Medicine NCBI PubMed database. Explore recent randomized trials in the PubMed Research Pulse .
Lipitor (Atorvastatin Calcium) Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $19.0681/unit (~$572.04/30u) | Wholesale baseline |
| Mark Cuban Cost Plus Drugs (Mail-Order Generic) | Public Wholesale Price List (NADAC + 15% + pharmacy fee) | $5.25 / mo | Formulary listing ↗ |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $34.50 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 22 Anonymous DotMD Community Micro-Logs | $7.50 / mo | View logs ↓ |
Lipitor (Atorvastatin Calcium) Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Lipitor (Atorvastatin Calcium) RxNorm Concept ID | 617312-B58151157 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $19.0681 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $34.50 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $5.25 / mo (Cost Plus Drugs) | Mark Cuban Cost Plus Public API |
| Real-World Patient Consensus | 75.00% Worth It (22 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Lipitor (Atorvastatin Calcium) Patient Community, Cohort Filters & Dosage Logs
Evidence synthesis for Lipitor (Atorvastatin Calcium): FDA labeling (2026-05-06, NDC 58151-157), CYP/interaction screening, and public pharmacy acquisition costs.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Lipitor (Atorvastatin Calcium) community threads and patient logs by age, biological sex, dosage, and treatment duration.